Patient Guide: Study of Olaparib Plus Pembrolizumab Versus Chemotherapy Plus Pembrolizumab After Induction With First-Line Chemotherapy Plus Pembrolizumab in Triple Negative Breast Cancer (TNBC) (MK-7339-009/KEYLYNK-009)

We'll Help You Connect with This Trial

Quri.ai is a free clinical trial matching service. We help patients like you connect directly with research sites conducting this study.

  • Get matched to the right study location for you
  • Connect directly with study coordinators at 122 participating sites
  • Understand eligibility with our simplified screening tool
  • Free service - we're here to help you access clinical research
Trial ID: NCTNCT04191135
Status: ACTIVE_NOT_RECRUITING
Condition: Triple Negative Breast Neoplasms
Phase: PHASE2

Find a Study Location Near You

This study is available at 122 research sites. We'll help you connect with the location that's right for you.

Participating sites include:
  • Monterey, California
  • San Francisco, California
  • Santa Monica, California
  • • And 119 more locations - let us help you find the closest one

Loading interactive enrollment tools...

The full interactive experience will load momentarily